Dietary Supplements: Current Good Manufacturing Practice, Labeling and Premarket Notification Concise Reference

Dietary Supplements: Current Good Manufacturing Practice, Labeling and Premarket Notification Concise Reference

by Mindy J. Allport-Settle
Dietary Supplements: Current Good Manufacturing Practice, Labeling and Premarket Notification Concise Reference

Dietary Supplements: Current Good Manufacturing Practice, Labeling and Premarket Notification Concise Reference

by Mindy J. Allport-Settle

eBook

$28.99 

Available on Compatible NOOK Devices and the free NOOK Apps.
WANT A NOOK?  Explore Now

Related collections and offers

LEND ME® See Details

Overview

This book is designed to be a unified reference source for the U.S. Food and Drug Adminstration's Dietary Supplements regulations, guidance, and associated documents. Dietary Supplements Regulations and Guidance: * FDA Overview and Orientation * Introduction to Dietary Supplements * Part I: Regulations - Part 111: Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements - Part 101: Food Labeling - Part 190: Diettary Supplements * Part II: Legislative Acts and Significant Amendments - Dietary Supplement and Nonprescription Drug Consumer Protection Act - Dietary Supplement Health and Education Act of 1994 * Part III: Guidance and Associated Documents - Dietary Supplements Final Rule - Dietary Supplement Current Good Manufacturing Practices (CGMPs) and Interim Final Rule (IFR) Facts - Dietary Supplement Labeling Guide - Structure/Function Claims, Small Entity Compliance Guide - Notification of a Health Claim or Nutrient Content Claim Based on an Authoritative Statement of a Scientific Body - Questions and Answers Regarding Adverse Event Reporting and Recordkeeping for Dietary Supplements as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act - Responses to Questions about Codex and Dietary Supplements Reference Tools * Part IV: Combined Glossary and Index

Product Details

BN ID: 2940012095251
Publisher: PharmaLogika
Publication date: 10/24/2010
Sold by: Barnes & Noble
Format: eBook
Pages: 426
File size: 620 KB

About the Author

Mindy Allport-Settle has served as a key executive, board member, and consultant for some of the best companies in the pharmaceutical, medical device, and biotechnology industry. She has provided guidance in regulatory compliance, corporate structuring, restructuring and turnarounds, new drug submissions, research and development, product commercialization strategies, operational, project and contract management, and new business development. Her experience and dedication have resulted in international recognition as the developer of the only FDA-recognized and benchmarked quality systems training and development business methodology. Her education includes a Bachelor's degree from the University of North Carolina, an MBA in Global Management from the University of Phoenix, and completion of the corporate governance course series in audit committees, compensation committees, and board effectiveness at Harvard Business School.
From the B&N Reads Blog

Customer Reviews